Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund

IndexDirect and Regular plans, Growth and IDCW options

Data as on 29-10-2026

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is a mutual fund run by Edelweiss Mutual Fund. On 30-09-2026, it managed ₹192 Cr of investors' money. In the 3 years to 29-10-2026, its Direct plan returned 21.9% a year and its Regular plan returned 21.2% a year.

NAV (Direct plan): ₹24.96; ▲ 1.42%29-10-2026
NAV (Regular plan): ₹24.13; ▲ 1.41%29-10-2026
Expense ratio: 0.55%Direct1.10%Regular; 0.55%; A year
Riskometer: Very High; Set by the fund house
3 year return: 21.9%Direct21.2%Regular; 21.9%; A year

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund NAV Today

NAV on 29-10-2026: Direct Plan Growth ₹24.96 (up 1.42% that day); Regular Plan Growth ₹24.13 (up 1.41% that day).

This fund (Direct plan)

₹24.9619

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Returns

Returns as on 29-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.

Trailing returns
Period	1M	3M	6M	1Y	3Y	5Y	10Y
This fund (Direct)	+0.39%	+0.72%	+16.41%	+19.24%	+21.85%	+14.80%	--
This fund (Regular)	+0.35%	+0.58%	+16.09%	+18.59%	+21.18%	+14.16%	--
Category average	--	--	--	--	--	--	--
Best in category	--	--	--	--	--	--	--
Worst in category	--	--	--	--	--	--	--
Rank in category	--	--	--	--	--	--	--

No category comparison is shown: this fund's category is too broad to compare, or has fewer than five funds. This fund's benchmark is MSCI India Domestic & World Healthcare 45 Index. Returns of that index are not available to us.

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Year-wise Returns

Return of each calendar year
Year	Direct	Regular
2026to date	+16.46%	+15.94%
2025	+5.48%	+4.91%
2024	+29.57%	+28.86%
2023	+25.11%	+24.41%
2022	−4.75%	−5.29%
2021	+18.78%	+18.03%

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Rolling Returns

The return of every holding period in the fund's history, not only the one that ends today

Rolling returns

Each point is the yearly return of one 3-year holding period, plotted on the day it ended. There are 713 periods, one for each trading day from 02-11-2023 to 29-10-2026.

0%5%10%15%20%25%

Jan 2021
to
Jan 2024Aug 2021
to
Aug 2024Feb 2022
to
Feb 2025Aug 2022
to
Aug 2025Feb 2023
to
Feb 2026Aug 2023
to
Aug 2026

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund (Direct)

Every holding period at a glance

Period	Periods	Median	Lowest	Highest	With a loss
1 year	1,189	13.3%	−10.4%	49.8%	19%
2 years	951	14.7%	1.3%	32.9%	0%
3 years	713	17.7%	11.0%	23.7%	0%
5 years	237	13.8%	12.3%	16.1%	0%

Period	Periods	Median	Lowest	Highest	With a loss
1 year	60	11.4%	−13.2%	49.6%	18%
2 years	48	14.0%	−4.4%	39.4%	4%
3 years	36	18.4%	8.6%	28.8%	0%

Lumpsum: the yearly rate (CAGR) from the NAV on a period's first day to the NAV on its last. SIP: the XIRR of the monthly instalments and their value on the last day. "With a loss" counts the periods that ended below the money put in. Past returns do not promise future returns.

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Risk

How much it swings, and the falls an investor had to sit through

Risk and return

Measure	Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund (Direct)This fund
Return (CAGR)	+19.24%
Standard deviation	11.28%
Sharpe ratio	1.24
Sortino ratio	1.86
Maximum drawdown	−6.6% (06-04-2026)

From daily NAVs, 29-10-2025 to 29-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls.

Measure	Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund (Direct)This fund
Return (CAGR)	+21.85%
Standard deviation	11.46%
Sharpe ratio	1.38
Sortino ratio	1.98
Maximum drawdown	−12.2% (07-04-2025)

From daily NAVs, 27-10-2023 to 29-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls.

Measure	Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund (Direct)This fund
Return (CAGR)	+14.80%
Standard deviation	11.49%
Sharpe ratio	0.78
Sortino ratio	1.13
Maximum drawdown	−16.1% (17-06-2022)

From daily NAVs, 29-10-2021 to 29-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls.

Measure	Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund (Direct)This fund
Return (CAGR)	+16.52%
Standard deviation	11.66%
Sharpe ratio	0.96
Sortino ratio	1.39
Maximum drawdown	−16.3% (17-06-2022)

From daily NAVs, 02-11-2020 to 29-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls.

Drawdowns

How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.

−20%−15%−10%−5%0%

202120222023202420252026

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund (Direct)

	Worst fall	High before it	Bottom	Back at the high	Time to climb back	Below its high today
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund (Direct)	−16.3%	03-09-2021	17-06-2022	15-06-2023	12 months	−0.96%

From the Direct plan's daily NAV since 02-11-2020, adjusted for unit splits. "Time to climb back" runs from the bottom to the first day back at the old high.

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Expense Ratio and Costs

What each plan charges a year, in force from 01-09-2026

Plan	Base expense ratio	Brokerage	Transaction costs	Levies and GST	Total expense ratio
Direct	0.43%	0.01%	0.00%	0.11%	0.55%
Regular	0.90%	0.01%	0.00%	0.19%	1.10%

The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, the cost of executing trades, and statutory levies with GST. From AMFI's expense ratio file.

Direct vs Regular: what the gap cost

Both plans own the same portfolio, so the difference in what they earned is the Regular plan's extra cost, taken out of its NAV.

Over the last	Regular	Direct	Direct earned more by	₹1 lakh became (Regular)	₹1 lakh became (Direct)
1 year	18.59%	19.24%	0.65%	₹1,18,590	₹1,19,240
3 years	21.18%	21.85%	0.67% a year	₹1,77,948	₹1,80,916
5 years	14.16%	14.80%	0.64% a year	₹1,93,896	₹1,99,393

Returns over more than 1 year are a rate a year (CAGR). ₹1 lakh invested once at the start of each period, valued on the last NAV.

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund SIP Calculator

What a one-time or monthly investment in this fund would be worth today, from its own NAV history

Growth of an investment

Every month₹

Step up each year

PeriodFor

₹10,000 on the first trading day of every month, from 02-11-2020 to 29-10-2026: 72 instalments, ₹7,20,000 in all.

Investment	Invested	Value now	Gain	Return a year
Direct planEdelweiss MSCI India Domestic & World Healthcare 45 Index Fund (Direct)	₹7,20,000	₹11,95,236	₹4,75,236	16.8%
Regular planEdelweiss MSCI India Domestic & World Healthcare 45 Index Fund (Regular)	₹7,20,000	₹11,72,689	₹4,52,689	16.2%

₹0₹5.0 L₹10.0 L₹15.0 L

202120222023202420252026

Direct planEdelweiss MSCI India Domestic & World Healthcare 45 Index Fund (Direct)Regular planEdelweiss MSCI India Domestic & World Healthcare 45 Index Fund (Regular)Amount invested

From each plan's published NAV (Growth option), over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Asset Allocation

Asset allocation as on 30-09-2026

What the fund holds

99.9%Equity

Asset	Fund
Equity	99.9%
Cash and others	0.1%

Market cap of stocks

Market cap	Fund
Large Cap	31.5%
Mid Cap	34.4%
Small Cap	2.7%
Foreign stocks	31.3%

Share of the whole fund. Groups follow AMFI's latest list, as SEBI defines them: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Sector Allocation

Sector allocation of the fund's stocks as on 30-09-2026

Largest sectors

Pharmaceuticals & Biotechnology55.2%
Pharmaceuticals16.1%
Healthcare Services14.3%
Biotechnology7.0%
Health Care Equipment & Supplies5.0%
Life Sciences Tools & Services2.4%

Sector changes

Sector	July 2026	August 2026	September 2026	Change
Pharmaceuticals & Biotechnology	54.4%	54.5%	55.2%	+0.8%
Pharmaceuticals	15.8%	15.9%	16.1%	+0.3%
Healthcare Services	16.2%	15.3%	14.3%	−1.9%
Biotechnology	6.5%	6.9%	7.0%	+0.5%
Health Care Equipment & Supplies	4.9%	5.1%	5.0%	+0.1%

Each sector's share of the fund at the end of each month. The five largest sectors of September 2026. Change: from July 2026 to September 2026, in % of the fund.

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Portfolio Holdings

As on 30-09-2026 · 45 holdings · from the fund house's monthly portfolio

Holdings	Sector	Weight%	1M change
Sun Pharmaceutical Industries Ltd.	Pharmaceuticals & Biotechnology	10.45%	−0.2%
Divi's Laboratories Ltd.	Pharmaceuticals & Biotechnology	7.09%	−0.2%
ELI LILLY & CO	Pharmaceuticals	6.46%	−2.7%
Apollo Hospitals Enterprise Ltd.	Healthcare Services	5.25%	−0.2%
JOHNSON & JOHNSON	Pharmaceuticals	4.45%	−2.4%
Laurus Labs Ltd.	Pharmaceuticals & Biotechnology	4.44%	−0.1%
Torrent Pharmaceuticals Ltd.	Pharmaceuticals & Biotechnology	4.38%	−0.2%
Cipla Ltd.	Pharmaceuticals & Biotechnology	4.34%	−0.2%
Max Healthcare Institute Ltd.	Healthcare Services	4.19%	−0.2%
Dr. Reddy's Laboratories Ltd.	Pharmaceuticals & Biotechnology	3.95%	−0.2%
ABBVIE INC	Biotechnology	3.22%	−2.5%
Lupin Ltd.	Pharmaceuticals & Biotechnology	2.97%	−0.2%
Aurobindo Pharma Ltd.	Pharmaceuticals & Biotechnology	2.77%	−1.1%
MERCK & CO.INC	Pharmaceuticals	2.50%	−2.5%
Fortis Healthcare Ltd.	Healthcare Services	2.41%	−0.2%
Glenmark Pharmaceuticals Ltd.	Pharmaceuticals & Biotechnology	2.11%	−0.2%
NOVARTIS AG	Pharmaceuticals	1.82%	−2.4%
THERMO FISHER SCIENTIFIC INC	Life Sciences Tools & Services	1.75%	−2.5%
IPCA Laboratories Ltd.	Pharmaceuticals & Biotechnology	1.72%	−0.2%
Mankind Pharma Ltd.	Pharmaceuticals & Biotechnology	1.65%	−0.1%
AMGEN INC	Biotechnology	1.59%	−2.3%
Biocon Ltd.	Pharmaceuticals & Biotechnology	1.47%	−4.1%
Alkem Laboratories Ltd.	Pharmaceuticals & Biotechnology	1.38%	−0.2%
Zydus Lifesciences Ltd.	Pharmaceuticals & Biotechnology	1.37%	−1.0%
Gland Pharma Ltd.	Pharmaceuticals & Biotechnology	1.37%	−0.1%
GILEAD SCIENCES INC	Biotechnology	1.29%	−2.3%
ABBOTT LABORATORIES	Health Care Equipment & Supplies	1.20%	−2.3%
Aster DM Quality Care Ltd.	Healthcare Services	1.04%	−0.2%
Ajanta Pharma Ltd.	Pharmaceuticals & Biotechnology	1.01%	−0.2%
INTUITIVE SURGICAL INC	Health Care Equipment & Supplies	1.00%	−2.6%
DANAHER CORP	Health Care Equipment & Supplies	0.98%	−2.4%
VERTEX PHARMACEUTICALS INC	Biotechnology	0.93%	−2.5%
Novo Nordisk A/S	Pharmaceuticals & Biotechnology	0.85%	−2.4%
MEDTRONIC PLC	Health Care Equipment & Supplies	0.77%	−2.6%
Narayana Hrudayalaya ltd.	Healthcare Services	0.70%	−0.2%
Global Health Ltd.	Healthcare Services	0.70%	−0.1%
GlaxoSmithKline Pharmaceuticals Ltd.	Pharmaceuticals & Biotechnology	0.67%	−0.2%
STRYKER CORP	Health Care Equipment & Supplies	0.66%	−2.2%
Wockhardt Ltd.	Pharmaceuticals & Biotechnology	0.62%	New
Anthem Biosciences Ltd.	Pharmaceuticals & Biotechnology	0.55%	+14.1%
Regeneron Pharmaceuticals Inc	Pharmaceuticals	0.55%	−2.7%
BECTON DICKINSON AND CO	Health Care Equipment & Supplies	0.34%	−5.7%
AGILENT TECHNOLOGIES INC	Life Sciences Tools & Services	0.34%	−2.5%
IQVIA HOLDINGS INC	Life Sciences Tools & Services	0.31%	−3.7%
WATERS CORP	Pharmaceuticals	0.30%	−2.1%

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Stocks Bought and Sold

All changes are between August 2026 and September 2026

Stocks bought and sold in September 2026

Sun Pharmaceutical Industries Ltd.	Reduced	−0.2%	10.45%
Divi's Laboratories Ltd.	Reduced	−0.2%	7.09%
ELI LILLY & CO	Reduced	−2.7%	6.46%
Apollo Hospitals Enterprise Ltd.	Reduced	−0.2%	5.25%
Max Healthcare Institute Ltd.	Reduced	−0.2%	4.19%
Torrent Pharmaceuticals Ltd.	Reduced	−0.2%	4.38%
JOHNSON & JOHNSON	Reduced	−2.4%	4.45%
Laurus Labs Ltd.	Reduced	−0.1%	4.44%
Cipla Ltd.	Reduced	−0.2%	4.34%
Dr. Reddy's Laboratories Ltd.	Reduced	−0.2%	3.95%
ABBVIE INC	Reduced	−2.5%	3.22%
Lupin Ltd.	Reduced	−0.2%	2.97%
Aurobindo Pharma Ltd.	Reduced	−1.1%	2.77%
Fortis Healthcare Ltd.	Reduced	−0.2%	2.41%
MERCK & CO.INC	Reduced	−2.5%	2.50%
Glenmark Pharmaceuticals Ltd.	Reduced	−0.2%	2.11%
NOVARTIS AG	Reduced	−2.4%	1.82%
THERMO FISHER SCIENTIFIC INC	Reduced	−2.5%	1.75%
IPCA Laboratories Ltd.	Reduced	−0.2%	1.72%
Mankind Pharma Ltd.	Reduced	−0.1%	1.65%
Biocon Ltd.	Reduced	−4.1%	1.47%
AMGEN INC	Reduced	−2.3%	1.59%
Alkem Laboratories Ltd.	Reduced	−0.2%	1.38%
Zydus Lifesciences Ltd.	Reduced	−1.0%	1.37%
Gland Pharma Ltd.	Reduced	−0.1%	1.37%
ABBOTT LABORATORIES	Reduced	−2.3%	1.20%
GILEAD SCIENCES INC	Reduced	−2.3%	1.29%
Aster DM Quality Care Ltd.	Reduced	−0.2%	1.04%
Ajanta Pharma Ltd.	Reduced	−0.2%	1.01%
INTUITIVE SURGICAL INC	Reduced	−2.6%	1.00%
Novo Nordisk A/S	Reduced	−2.4%	0.85%
DANAHER CORP	Reduced	−2.4%	0.98%
VERTEX PHARMACEUTICALS INC	Reduced	−2.5%	0.93%
MEDTRONIC PLC	Reduced	−2.6%	0.77%
STRYKER CORP	Reduced	−2.2%	0.66%
Global Health Ltd.	Reduced	−0.1%	0.70%
GlaxoSmithKline Pharmaceuticals Ltd.	Reduced	−0.2%	0.67%
Narayana Hrudayalaya ltd.	Reduced	−0.2%	0.70%
Wockhardt Ltd.	New	New	0.62%
Regeneron Pharmaceuticals Inc	Reduced	−2.7%	0.55%
Anthem Biosciences Ltd.	Added	+14.1%	0.55%
BECTON DICKINSON AND CO	Reduced	−5.7%	0.34%
AGILENT TECHNOLOGIES INC	Reduced	−2.5%	0.34%
IQVIA HOLDINGS INC	Reduced	−3.7%	0.31%
WATERS CORP	Reduced	−2.1%	0.30%

A change is counted by the number of shares the fund holds, not by price. A stock can become a smaller part of the fund in a month when the fund bought more of it, if its price fell. Debt papers are left out.

What Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund bought and sold

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Portfolio Overlap

Funds with the most similar portfolios, across every fund house and category

Fund	Overlap	Holdings in common
Bandhan BSE Healthcare Index FundIndex · Bandhan	68.5%	25	Compare
Mirae Asset Nifty 500 Healthcare ETFETF · Mirae Asset	68.3%	25	Compare
Motilal Oswal BSE Healthcare ETFETF · Motilal Oswal	67.7%	25	Compare
DSP Nifty Healthcare ETFETF · DSP	63.3%	18	Compare
DSP Nifty Healthcare Index FundIndex · DSP	63.3%	18	Compare
Aditya Birla Sun Life Nifty Healthcare ETFETF · Aditya Birla Sun Life	63.3%	18	Compare
Axis NIFTY Healthcare ETFETF · Axis	63.3%	18	Compare
ICICI Prudential Nifty Healthcare ETFETF · ICICI Prudential	63.3%	18	Compare

Overlap: for each holding both funds own, the smaller of its two weights, added up. 40% means 40% of each fund's money sits in positions the other also holds. From each fund's latest monthly portfolio, matched by ISIN. Cash and hedged positions are left out. Funds that overlap under 10% are not listed. A high overlap does not make two funds the same: their costs, lock-in and category can differ.

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Overview

Fund facts from the scheme summary document, as on 16-10-2026

Expense ratio (Direct): 0.55%
Expense ratio (Regular): 1.10%
Category: Index
Risk: Very High
Launch date: 26-10-2020
Minimum investment: Not available
Minimum additional investment: Not available
AUM: ₹191.85 Cr (30-09-2026)
Lock in: None
Scheme code (Direct): 148555
ISIN (Direct): INF754K01LV5
Scheme code (Regular): 148557
ISIN (Regular): INF754K01LR3
NAV history: From 02-11-2020, 6.0 years

Benchmark: MSCI India Domestic & World Healthcare 45 Index
Exit load: Nil

Tax on Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund returns

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is taxed as an equity fund: 65% or more of it is in Indian stocks.
Units sold within 1 year: the gain is taxed at 20%.
Units held longer: gains above ₹1.25 lakh in a financial year, across all your equity funds and shares, are taxed at 12.5%.
IDCW (dividend) payouts are added to your income and taxed at your slab rate.
A stamp duty of 0.005% is deducted when you invest.

Rules in force from 23-07-2024 (Finance Act 2024). Tax depends on your own income; this is general information, not tax advice.

All plans and options

Plan	Option	NAV	As on
direct	Growth	₹24.9619	29-10-2026
direct	IDCW	₹22.0173	29-10-2026
regular	Growth	₹24.1273	29-10-2026
regular	IDCW	₹21.1861	29-10-2026

About Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is a mutual fund from Edelweiss Mutual Fund. Its category is Index. It was launched on 26-10-2020. Its benchmark is MSCI India Domestic & World Healthcare 45 Index. At the end of September 2026 it held 45 securities.

Fund Manager

Bhavesh Jain
Fund manager of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund, since 01-10-2021
Manasi Jalgaonkar
Fund manager of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund, since 01-04-2026
Amit Vora
Fund manager of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund, since 02-12-2021

See all funds of Edelweiss Mutual Fund

AUM change

September 2026: ₹191.85 Cr; −3.89% from August 2026
August 2026: ₹199.62 Cr; +2.11% from July 2026
July 2026: ₹195.49 Cr; +3.49% from June 2026

AUM moves with money invested or taken out, and with the value of what the fund holds.

Compare Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund with Other Funds

Returns, risk, costs and the stocks they share, side by side

Compare with any other fund

Frequently Asked Questions for Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund

What is the current NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund?

The Direct plan NAV is ₹24.9619. The Regular plan NAV is ₹24.1273, as on 29-10-2026.

What are the returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund?

The Direct plan returned +19.24% in 1 year, +21.85% a year over 3 years, +14.80% a year over 5 years. The Regular plan returned +18.59% in 1 year, +21.18% a year over 3 years, +14.16% a year over 5 years. These figures are as on 29-10-2026.

What is the expense ratio of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund?

The Direct plan charges 0.55% a year. The Regular plan charges 1.10% a year. This is the figure the fund house reported to AMFI, in force from 01-09-2026.

What is the AUM of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund?

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund managed ₹191.85 Cr on 30-09-2026, as its fund house reported in its monthly portfolio.

What are the top holdings of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund?

At the end of September 2026 the largest holdings were SUNPHARMA (10.45%), DIVISLAB (7.09%), ELI LILLY & CO (6.46%), APOLLOHOSP (5.25%), JOHNSON & JOHNSON (4.45%). The fund held 45 securities in all.

What did Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund buy and sell in September 2026?

It bought 1 new stock: Wockhardt Ltd. It added shares in 1. It reduced 43.

How do I invest in Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund?

Through Edelweiss Mutual Fund's website or app, a mutual fund distributor, or an investment platform. Choose the Direct plan to pay no distributor commission, or the Regular plan to invest through a distributor. You can invest once or through a monthly SIP.

Who is the fund manager of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund?

Bhavesh Jain (since 01-10-2021), Manasi Jalgaonkar (since 01-04-2026), Amit Vora (since 02-12-2021).

Sources: NAV and expense ratio from AMFI. Holdings from the fund house's monthly portfolio statement. Fund facts from its scheme summary document, as on 16-10-2026.

This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.